Well done to the PTX team.
Encouraging progress for sure, data pointing in the right direction on this extension P1 study.
Has been a long awaited and hopeful drug to test clinically ( Ptx 100) and, on it’s own merits, worth continuing it’s progress.
Early days yet, if a registered P2 study gets approved by the FDA… and efficacy on a larger cohort remains or even exceeds, then a more standardised result can be claimed.
A big thank you to all the volunteers thus far, and a warm congratulations to the ones now with a better quality of life.
Again, congrats to the PTX team and co-founders of this promising drug.
Well done to the PTX team.Encouraging progress for sure, data...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
-0.002(4.17%) |
Mkt cap ! $37.04M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.6¢ | $94.55K | 2.033M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7000 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 550000 | 2 |
View Market Depth
| Last trade - 15.36pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.8¢ |
Change
-0.002 ( 2.04 %) |
||||
| Open | High | Low | Volume | ||
| 4.7¢ | 4.8¢ | 4.5¢ | 409565 | ||
| Last updated 15.51pm 03/05/2024 ? | |||||
| PTX (ASX) Chart |